Dr Samuel Blay Nguah FWACP FGCPS
id
= Study IDtreat
= Treatment givenage
= Age of participantsex
= Sex of patientbp1
= Initial mean arterial BPbp2
= Final mean arterial BPid | treat | age | sex | bp1 | bp2 |
---|---|---|---|---|---|
C1 | 0 | 63 | F | 97.4 | 93.1 |
C2 | 0 | NA | F | 97.2 | 92.4 |
C6 | 0 | 62 | F | 103.4 | 99.7 |
C7 | 0 | 61 | F | 290.1 | 88.4 |
C9 | 0 | 73 | F | 96.4 | 91.1 |
C10 | 0 | 57 | F | 98.6 | 90.5 |
C13 | 0 | 61 | F | 97.4 | 93.8 |
C14 | 0 | 999 | F | 97.4 | 92.6 |
A18 | 0 | 51 | F | 92.2 | 86.2 |
A20 | 0 | 65 | F | 96.9 | 90.4 |
A21 | NA | 65 | F | 102.6 | 91.5 |
C3 | 0 | 54 | M | 98.8 | 94.6 |
C4 | 0 | 69 | M | 98.4 | 92.3 |
C5 | 0 | 75 | M | 89.8 | 89.3 |
C8 | 0 | 59 | M | 93.7 | 90.4 |
id treat age sex Length:50 Min. :0.0000 Min. : 45.00 Length:50 Class :character 1st Qu.:0.0000 1st Qu.: 57.75 Class :character Mode :character Median :1.0000 Median : 63.00 Mode :character Mean :0.5714 Mean : 81.00 3rd Qu.:1.0000 3rd Qu.: 65.00 Max. :1.0000 Max. :999.00 NA's :1 NA's :2 bp1 bp2 Min. : 87.5 Min. :78.00 1st Qu.: 96.0 1st Qu.:85.20 Median : 98.0 Median :88.40 Mean :102.4 Mean :88.61 3rd Qu.:101.2 3rd Qu.:92.30 Max. :290.1 Max. :99.70 NA's :1 NA's :1
sex
to categorical variable (factor)treat
to categorical variablebp_diff
= Difference in BPage_group
: id treat age sex bp1 Length:50 Old Drug:22 Min. :45.00 Female:26 Min. : 87.50 Class :character New Drug:28 1st Qu.:57.25 Male :24 1st Qu.: 95.62 Mode :character Median :63.00 Median : 97.70 Mean :61.48 Mean : 98.30 3rd Qu.:65.00 3rd Qu.: 99.40 Max. :75.00 Max. :111.70 bp2 bp_diff age_group Min. :78.00 Min. : 0.500 Middle age:17 1st Qu.:85.22 1st Qu.: 4.800 Elderly :33 Median :88.15 Median : 8.250 Mean :88.60 Mean : 9.704 3rd Qu.:92.10 3rd Qu.:13.700 Max. :99.70 Max. :26.300
Characteristic | N = 50 |
---|---|
Treatment Type, n (%) | |
Old Drug | 22 (44.0) |
New Drug | 28 (56.0) |
Sex, n (%) | |
Female | 26 (52.0) |
Male | 24 (48.0) |
Age Grouping, n (%) | |
Middle age | 17 (34.0) |
Elderly | 33 (66.0) |
Treatment Type | Total | ||
---|---|---|---|
Old Drug | New Drug | ||
Sex | |||
Female | 11 (42%) | 15 (58%) | 26 (100%) |
Male | 11 (46%) | 13 (54%) | 24 (100%) |
Total | 22 (44%) | 28 (56%) | 50 (100%) |
Characteristic | 1">Overall, N = 501 | Treatment given | |
---|---|---|---|
Old Drug, N = 22 | New Drug, N = 28 | ||
Sex, n (%) | |||
Female | 26 (52.0) | 11 (50.0) | 15 (53.6) |
Male | 24 (48.0) | 11 (50.0) | 13 (46.4) |
Age Grouping, n (%) | |||
Middle age | 17 (34.0) | 7 (31.8) | 10 (35.7) |
Elderly | 33 (66.0) | 15 (68.2) | 18 (64.3) |
1 n (%) |
Pie Chart
Bar Chart - Univariate
Barchart - Bivariate
Re=28200=0.14=14%
=Risk of getting the disease(Risk of not getting the disease) Oddse=0.141−0.14=0.140.86≈0.16
=Incidence in the exposedIncidence in the non−exposed=ReRu
=Odds in the exposedOdds in the non−exposed=OddseOddsu
Characteristic | N = 50 |
---|---|
Initial blood pressure (mmHg) | |
Median (IQR) | 97.7 (95.6, 99.4) |
Mean (SD) | 98.3 (5.2) |
Range | 87.5, 111.7 |
Blood Pressure after treatment | |
Median (IQR) | 88.2 (85.2, 92.1) |
Mean (SD) | 88.6 (4.6) |
Range | 78.0, 99.7 |
Characteristic | Old Drug, N = 22 | New Drug, N = 28 |
---|---|---|
Initial blood pressure (mmHg) | ||
Median (IQR) | 97.4 (95.5, 98.8) | 98.3 (95.9, 101.7) |
Mean (SD) | 97.1 (3.6) | 99.2 (6.0) |
Range | 89.8, 103.4 | 87.5, 111.7 |
Blood Pressure after treatment | ||
Median (IQR) | 91.9 (90.4, 93.6) | 85.4 (84.4, 87.2) |
Mean (SD) | 92.2 (3.3) | 85.8 (3.3) |
Range | 86.2, 99.7 | 78.0, 94.2 |
Confidence interval
The 95% confidence interval is the interval that is likely to contain the population parameter 95% of the time.
It is the probability of having a statistic as extreme as the one observed from the sample if the null hypothesis is true. It determines the strength of support for the null hypothesis.
Generally:
Characteristic | 1">Old Drug, N = 221 | 2">95% CI2 | 1">New Drug, N = 281 | 2">95% CI2 |
---|---|---|---|---|
Change in Blood Pressure | 4.9 (2.3) | 3.9, 5.9 | 13.4 (5.7) | 11, 16 |
1 Mean (SD) | ||||
2 CI = Confidence Interval |
H0: No difference in BP lowering effect between the two drugs
Characteristic | 1">Old Drug, N = 221 | 1">New Drug, N = 281 | 2">p-value2 |
---|---|---|---|
Change in Blood Pressure | 4.9 (2.3) | 13.4 (5.7) | <0.001 |
1 Mean (SD) | |||
2 Welch Two Sample t-test |
Conclusion: Based on the p-value we reject the H0 and thus conclude there is a significant difference between the BP lowering effect of the New drug and Control
H0: BP lowering effect is not related to age
Characteristic | Beta | 1">95% CI1 | p-value |
---|---|---|---|
Age in years | 0.08 | -0.19, 0.36 | 0.5 |
1 CI = Confidence Interval |
Conclusion: BP lowering effect not significantly related to the age of the patient.
Characteristic | 1">Overall, N = 501 | Drug | 2">p-value2 | |
---|---|---|---|---|
1">Old Drug, N = 221 | 1">New Drug, N = 281 | |||
Age in years | 61.5 (6.5) | 62.1 (6.6) | 61.0 (6.5) | 0.6 |
Sex | 0.8 | |||
Female | 26.0 (52.0%) | 11.0 (50.0%) | 15.0 (53.6%) | |
Male | 24.0 (48.0%) | 11.0 (50.0%) | 13.0 (46.4%) | |
Initial blood pressure (mmHg) | 98.3 (5.2) | 97.1 (3.6) | 99.2 (6.0) | 0.13 |
Blood Pressure after treatment | 88.6 (4.6) | 92.2 (3.3) | 85.8 (3.3) | <0.001 |
Change in Blood Pressure | 9.7 (6.2) | 4.9 (2.3) | 13.4 (5.7) | <0.001 |
Age Grouping | 0.8 | |||
Middle age | 17.0 (34.0%) | 7.0 (31.8%) | 10.0 (35.7%) | |
Elderly | 33.0 (66.0%) | 15.0 (68.2%) | 18.0 (64.3%) | |
1 Mean (SD); n (%) | ||||
2 Welch Two Sample t-test; Pearson’s Chi-squared test |
Thank you!!!
Keyboard shortcuts
↑, ←, Pg Up, k | Go to previous slide |
↓, →, Pg Dn, Space, j | Go to next slide |
Home | Go to first slide |
End | Go to last slide |
Number + Return | Go to specific slide |
b / m / f | Toggle blackout / mirrored / fullscreen mode |
c | Clone slideshow |
p | Toggle presenter mode |
t | Restart the presentation timer |
?, h | Toggle this help |
o | Tile View: Overview of Slides |
s | Toggle scribble toolbox |
Esc | Back to slideshow |
Dr Samuel Blay Nguah FWACP FGCPS
id
= Study IDtreat
= Treatment givenage
= Age of participantsex
= Sex of patientbp1
= Initial mean arterial BPbp2
= Final mean arterial BPid | treat | age | sex | bp1 | bp2 |
---|---|---|---|---|---|
C1 | 0 | 63 | F | 97.4 | 93.1 |
C2 | 0 | NA | F | 97.2 | 92.4 |
C6 | 0 | 62 | F | 103.4 | 99.7 |
C7 | 0 | 61 | F | 290.1 | 88.4 |
C9 | 0 | 73 | F | 96.4 | 91.1 |
C10 | 0 | 57 | F | 98.6 | 90.5 |
C13 | 0 | 61 | F | 97.4 | 93.8 |
C14 | 0 | 999 | F | 97.4 | 92.6 |
A18 | 0 | 51 | F | 92.2 | 86.2 |
A20 | 0 | 65 | F | 96.9 | 90.4 |
A21 | NA | 65 | F | 102.6 | 91.5 |
C3 | 0 | 54 | M | 98.8 | 94.6 |
C4 | 0 | 69 | M | 98.4 | 92.3 |
C5 | 0 | 75 | M | 89.8 | 89.3 |
C8 | 0 | 59 | M | 93.7 | 90.4 |
id treat age sex Length:50 Min. :0.0000 Min. : 45.00 Length:50 Class :character 1st Qu.:0.0000 1st Qu.: 57.75 Class :character Mode :character Median :1.0000 Median : 63.00 Mode :character Mean :0.5714 Mean : 81.00 3rd Qu.:1.0000 3rd Qu.: 65.00 Max. :1.0000 Max. :999.00 NA's :1 NA's :2 bp1 bp2 Min. : 87.5 Min. :78.00 1st Qu.: 96.0 1st Qu.:85.20 Median : 98.0 Median :88.40 Mean :102.4 Mean :88.61 3rd Qu.:101.2 3rd Qu.:92.30 Max. :290.1 Max. :99.70 NA's :1 NA's :1
sex
to categorical variable (factor)treat
to categorical variablebp_diff
= Difference in BPage_group
: id treat age sex bp1 Length:50 Old Drug:22 Min. :45.00 Female:26 Min. : 87.50 Class :character New Drug:28 1st Qu.:57.25 Male :24 1st Qu.: 95.62 Mode :character Median :63.00 Median : 97.70 Mean :61.48 Mean : 98.30 3rd Qu.:65.00 3rd Qu.: 99.40 Max. :75.00 Max. :111.70 bp2 bp_diff age_group Min. :78.00 Min. : 0.500 Middle age:17 1st Qu.:85.22 1st Qu.: 4.800 Elderly :33 Median :88.15 Median : 8.250 Mean :88.60 Mean : 9.704 3rd Qu.:92.10 3rd Qu.:13.700 Max. :99.70 Max. :26.300
Characteristic | N = 50 |
---|---|
Treatment Type, n (%) | |
Old Drug | 22 (44.0) |
New Drug | 28 (56.0) |
Sex, n (%) | |
Female | 26 (52.0) |
Male | 24 (48.0) |
Age Grouping, n (%) | |
Middle age | 17 (34.0) |
Elderly | 33 (66.0) |
Treatment Type | Total | ||
---|---|---|---|
Old Drug | New Drug | ||
Sex | |||
Female | 11 (42%) | 15 (58%) | 26 (100%) |
Male | 11 (46%) | 13 (54%) | 24 (100%) |
Total | 22 (44%) | 28 (56%) | 50 (100%) |
Characteristic | 1">Overall, N = 501 | Treatment given | |
---|---|---|---|
Old Drug, N = 22 | New Drug, N = 28 | ||
Sex, n (%) | |||
Female | 26 (52.0) | 11 (50.0) | 15 (53.6) |
Male | 24 (48.0) | 11 (50.0) | 13 (46.4) |
Age Grouping, n (%) | |||
Middle age | 17 (34.0) | 7 (31.8) | 10 (35.7) |
Elderly | 33 (66.0) | 15 (68.2) | 18 (64.3) |
1 n (%) |
Pie Chart
Bar Chart - Univariate
Barchart - Bivariate
Re=28200=0.14=14%
=Risk of getting the disease(Risk of not getting the disease) Oddse=0.141−0.14=0.140.86≈0.16
=Incidence in the exposedIncidence in the non−exposed=ReRu
=Odds in the exposedOdds in the non−exposed=OddseOddsu
Characteristic | N = 50 |
---|---|
Initial blood pressure (mmHg) | |
Median (IQR) | 97.7 (95.6, 99.4) |
Mean (SD) | 98.3 (5.2) |
Range | 87.5, 111.7 |
Blood Pressure after treatment | |
Median (IQR) | 88.2 (85.2, 92.1) |
Mean (SD) | 88.6 (4.6) |
Range | 78.0, 99.7 |
Characteristic | Old Drug, N = 22 | New Drug, N = 28 |
---|---|---|
Initial blood pressure (mmHg) | ||
Median (IQR) | 97.4 (95.5, 98.8) | 98.3 (95.9, 101.7) |
Mean (SD) | 97.1 (3.6) | 99.2 (6.0) |
Range | 89.8, 103.4 | 87.5, 111.7 |
Blood Pressure after treatment | ||
Median (IQR) | 91.9 (90.4, 93.6) | 85.4 (84.4, 87.2) |
Mean (SD) | 92.2 (3.3) | 85.8 (3.3) |
Range | 86.2, 99.7 | 78.0, 94.2 |
Confidence interval
The 95% confidence interval is the interval that is likely to contain the population parameter 95% of the time.
It is the probability of having a statistic as extreme as the one observed from the sample if the null hypothesis is true. It determines the strength of support for the null hypothesis.
Generally:
Characteristic | 1">Old Drug, N = 221 | 2">95% CI2 | 1">New Drug, N = 281 | 2">95% CI2 |
---|---|---|---|---|
Change in Blood Pressure | 4.9 (2.3) | 3.9, 5.9 | 13.4 (5.7) | 11, 16 |
1 Mean (SD) | ||||
2 CI = Confidence Interval |
H0: No difference in BP lowering effect between the two drugs
Characteristic | 1">Old Drug, N = 221 | 1">New Drug, N = 281 | 2">p-value2 |
---|---|---|---|
Change in Blood Pressure | 4.9 (2.3) | 13.4 (5.7) | <0.001 |
1 Mean (SD) | |||
2 Welch Two Sample t-test |
Conclusion: Based on the p-value we reject the H0 and thus conclude there is a significant difference between the BP lowering effect of the New drug and Control
H0: BP lowering effect is not related to age
Characteristic | Beta | 1">95% CI1 | p-value |
---|---|---|---|
Age in years | 0.08 | -0.19, 0.36 | 0.5 |
1 CI = Confidence Interval |
Conclusion: BP lowering effect not significantly related to the age of the patient.
Characteristic | 1">Overall, N = 501 | Drug | 2">p-value2 | |
---|---|---|---|---|
1">Old Drug, N = 221 | 1">New Drug, N = 281 | |||
Age in years | 61.5 (6.5) | 62.1 (6.6) | 61.0 (6.5) | 0.6 |
Sex | 0.8 | |||
Female | 26.0 (52.0%) | 11.0 (50.0%) | 15.0 (53.6%) | |
Male | 24.0 (48.0%) | 11.0 (50.0%) | 13.0 (46.4%) | |
Initial blood pressure (mmHg) | 98.3 (5.2) | 97.1 (3.6) | 99.2 (6.0) | 0.13 |
Blood Pressure after treatment | 88.6 (4.6) | 92.2 (3.3) | 85.8 (3.3) | <0.001 |
Change in Blood Pressure | 9.7 (6.2) | 4.9 (2.3) | 13.4 (5.7) | <0.001 |
Age Grouping | 0.8 | |||
Middle age | 17.0 (34.0%) | 7.0 (31.8%) | 10.0 (35.7%) | |
Elderly | 33.0 (66.0%) | 15.0 (68.2%) | 18.0 (64.3%) | |
1 Mean (SD); n (%) | ||||
2 Welch Two Sample t-test; Pearson’s Chi-squared test |
Thank you!!!